Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: Wiener klinische Wochenschrift 3-4/2014

01.02.2014 | original article

Atrial electromechanical delay in type 2 diabetes mellitus

verfasst von: MD Ahmet Akyel, MD Fatih Öksüz, MD Muhammed Karadeniz, MD Mikail Yarlıoğlueş, MD Gökhan Ergün, MD Tayyar Cankurt, MD Ahmet Yozgat, MD Müge Keskin Arıel, MD Yalçın Aral, MD Sani Namık Murat

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 3-4/2014

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

Background

Diabetes mellitus (DM) is an independent risk factor for atrial fibrillation (AF). Increased atrial electromechanical delay (AEMD) is known to be a precursor of AF. In this study, we aimed to investigate AEMD in patients with type 2 DM.

Methods

A total of 110 participants were recruited to the present study. Of them, 70 were diabetic patients, and 40 were healthy control subjects. Basal characteristics were recorded and transthoracic echocardiography was performed for all study participants.

Results

Basal characteristics were similar between the two groups. There was significant intra-atrial and interatrial electromechanical delay in the diabetic group compared with the control group. In the correlation analysis, no correlation existed between AEMD and hemoglobin A1C or fasting plasma glucose levels.

Conclusion

In the present study, we showed that there was significant AEMD in patients with type 2 DM compared with healthy control subjects. Increased AEMD might be an early marker of AF in this patient subset. To clear this hypothesis, further studies are needed.
Literatur
1.
Zurück zum Zitat Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994 Mar 16;271(11):840–4. PubMedCrossRef Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994 Mar 16;271(11):840–4. PubMedCrossRef
2.
Zurück zum Zitat Camm AJ, Lip GY, De Caterina R, et al. ESC Committee for Practice Guidelines-CPG; Document Reviewers. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation—developed with the special contribution of the European Heart Rhythm Association. Europace. 2012 Oct;14(10):1385–413. PubMedCrossRef Camm AJ, Lip GY, De Caterina R, et al. ESC Committee for Practice Guidelines-CPG; Document Reviewers. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation—developed with the special contribution of the European Heart Rhythm Association. Europace. 2012 Oct;14(10):1385–413. PubMedCrossRef
3.
Zurück zum Zitat Cui QQ, Zhang W, Wang H, et al. Assessment of atrial electromechanical coupling and influential factors in nonrheumatic paroxysmal atrial fibrillation. Clin Cardiol. 2008 Feb;31(2):74–8. PubMedCrossRef Cui QQ, Zhang W, Wang H, et al. Assessment of atrial electromechanical coupling and influential factors in nonrheumatic paroxysmal atrial fibrillation. Clin Cardiol. 2008 Feb;31(2):74–8. PubMedCrossRef
4.
Zurück zum Zitat Deniz A, Sahiner L, Aytemir K, Kaya B, Kabakci G, Tokgozoglu L, Oto A. Tissue Doppler echocardiography can be a useful technique to evaluate atrial conduction time. Cardiol J. 2012;19(5):487–93. PubMedCrossRef Deniz A, Sahiner L, Aytemir K, Kaya B, Kabakci G, Tokgozoglu L, Oto A. Tissue Doppler echocardiography can be a useful technique to evaluate atrial conduction time. Cardiol J. 2012;19(5):487–93. PubMedCrossRef
5.
Zurück zum Zitat American Diabetes Association.  Executive summary: standards of medical care in diabetes—2011. Diabetes Care. 2011 Jan;34 Suppl 1:S11–61. CrossRef American Diabetes Association.  Executive summary: standards of medical care in diabetes—2011. Diabetes Care. 2011 Jan;34 Suppl 1:S11–61. CrossRef
6.
Zurück zum Zitat Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. JAMA. 2001;285:2486–97. CrossRef Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. JAMA. 2001;285:2486–97. CrossRef
7.
Zurück zum Zitat Aksnes TA, Schmieder RE, Kjeldsen SE, Ghani S, Hua TA, Julius S. Impact of new-onset diabetes mellitus on development of atrial fibrillation and heart failure in high-risk hypertension (from the VALUE Trial). Am J Cardiol. 2008 Mar 1;101(5):634–8. PubMedCrossRef Aksnes TA, Schmieder RE, Kjeldsen SE, Ghani S, Hua TA, Julius S. Impact of new-onset diabetes mellitus on development of atrial fibrillation and heart failure in high-risk hypertension (from the VALUE Trial). Am J Cardiol. 2008 Mar 1;101(5):634–8. PubMedCrossRef
8.
Zurück zum Zitat Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001 May 9;285(18):2370–5. PubMedCrossRef Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001 May 9;285(18):2370–5. PubMedCrossRef
9.
Zurück zum Zitat Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995 May;98(5):476–84. PubMedCrossRef Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995 May;98(5):476–84. PubMedCrossRef
10.
Zurück zum Zitat Klem I, Wehinger C, Schneider B, Hartl E, Finsterer J, Stöllberger C. Diabetic atrial fibrillation patients: mortality and risk for stroke or embolism during a 10-year follow-up. Diabetes Metab Res Rev. 2003 Jul-Aug;19(4):320–8. PubMedCrossRef Klem I, Wehinger C, Schneider B, Hartl E, Finsterer J, Stöllberger C. Diabetic atrial fibrillation patients: mortality and risk for stroke or embolism during a 10-year follow-up. Diabetes Metab Res Rev. 2003 Jul-Aug;19(4):320–8. PubMedCrossRef
11.
Zurück zum Zitat Movahed MR, Hashemzadeh M, Jamal MM. Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol. 2005 Dec 7;105(3):315–8. PubMedCrossRef Movahed MR, Hashemzadeh M, Jamal MM. Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol. 2005 Dec 7;105(3):315–8. PubMedCrossRef
12.
Zurück zum Zitat Kato T, Yamashita T, Sekiguchi A, et al. What are arrhythmogenic substrates in diabetic rat atria? J Cardiovasc Electrophysiol. 2006 Aug;17(8):890–4. PubMedCrossRef Kato T, Yamashita T, Sekiguchi A, et al. What are arrhythmogenic substrates in diabetic rat atria? J Cardiovasc Electrophysiol. 2006 Aug;17(8):890–4. PubMedCrossRef
13.
Zurück zum Zitat Fu H, Liu C, Li J, Zhou C, Cheng L, Liu T, Li G. Impaired atrial electromechanical function and atrial fibrillation promotion in alloxan-induced diabetic rabbits. Cardiol J. 2013;20(1):59–67. PubMedCrossRef Fu H, Liu C, Li J, Zhou C, Cheng L, Liu T, Li G. Impaired atrial electromechanical function and atrial fibrillation promotion in alloxan-induced diabetic rabbits. Cardiol J. 2013;20(1):59–67. PubMedCrossRef
14.
Zurück zum Zitat Chao TF, Suenari K, Chang SL, et al. Atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fibrillation associated with diabetes mellitus or impaired fasting glucose. Am J Cardiol. 2010 Dec 1;106(11):1615–20. PubMedCrossRef Chao TF, Suenari K, Chang SL, et al. Atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fibrillation associated with diabetes mellitus or impaired fasting glucose. Am J Cardiol. 2010 Dec 1;106(11):1615–20. PubMedCrossRef
15.
Zurück zum Zitat Pytkowski M, Jankowska A, Maciag A, et al. Paroxysmal atrial fibrillation is associated with increased intra-atrial conduction delay. Europace. 2008 Dec;10(12):1415–20. PubMedCrossRef Pytkowski M, Jankowska A, Maciag A, et al. Paroxysmal atrial fibrillation is associated with increased intra-atrial conduction delay. Europace. 2008 Dec;10(12):1415–20. PubMedCrossRef
16.
Zurück zum Zitat De Vos CB, Weijs B, Crijns HJ, et al. Atrial tissue Doppler imaging for prediction of new-onset atrial fibrillation. Heart. 2009 May;95(10):835–40. PubMedCrossRef De Vos CB, Weijs B, Crijns HJ, et al. Atrial tissue Doppler imaging for prediction of new-onset atrial fibrillation. Heart. 2009 May;95(10):835–40. PubMedCrossRef
17.
Zurück zum Zitat Chao TF, Sung SH, Wang KL, et al. Associations between the atrial electromechanical interval, atrial remodelling and outcome of catheter ablation in paroxysmal atrial fibrillation. Heart. 2011;97:225–30. PubMedCrossRef Chao TF, Sung SH, Wang KL, et al. Associations between the atrial electromechanical interval, atrial remodelling and outcome of catheter ablation in paroxysmal atrial fibrillation. Heart. 2011;97:225–30. PubMedCrossRef
18.
Zurück zum Zitat Kurt M, Tanboğa IH, Karakas¸ MF, Büyükkaya E, Akcay AB, Sen N, Bilen E. The relationship between atrial electromechanical delay and P-wave dispersion with the presence and severity of metabolic syndrome. Turk Kardiyol Dern Ars. 2012 Dec;40(8):663–70. PubMedCrossRef Kurt M, Tanboğa IH, Karakas¸ MF, Büyükkaya E, Akcay AB, Sen N, Bilen E. The relationship between atrial electromechanical delay and P-wave dispersion with the presence and severity of metabolic syndrome. Turk Kardiyol Dern Ars. 2012 Dec;40(8):663–70. PubMedCrossRef
19.
Zurück zum Zitat Ayhan S, Ozturk S, Alcelik A, et al. Atrial conduction time and atrial mechanical function in patients with impaired fasting glucose. J Interv Card Electrophysiol. 2012 Dec;35(3):247–52. PubMedCrossRef Ayhan S, Ozturk S, Alcelik A, et al. Atrial conduction time and atrial mechanical function in patients with impaired fasting glucose. J Interv Card Electrophysiol. 2012 Dec;35(3):247–52. PubMedCrossRef
20.
Zurück zum Zitat Acar G, Akcay A, Sokmen A, et al. Assessment of atrial electromechanical delay, diastolic functions, and left atrial mechanical functions in patients with type 1 diabetes mellitus. J Am Soc Echocardiogr. 2009 Jun;22(6):732–8. PubMedCrossRef Acar G, Akcay A, Sokmen A, et al. Assessment of atrial electromechanical delay, diastolic functions, and left atrial mechanical functions in patients with type 1 diabetes mellitus. J Am Soc Echocardiogr. 2009 Jun;22(6):732–8. PubMedCrossRef
21.
Zurück zum Zitat Hung CL, Chao TF, Lai YH, et al. The relationship among atrium electromechanical interval, insulin resistance, and metabolic syndrome. Can J Cardiol. 2013 Mar 13. doi:10.1016/j.cjca.2013.01.001. Hung CL, Chao TF, Lai YH, et al. The relationship among atrium electromechanical interval, insulin resistance, and metabolic syndrome. Can J Cardiol. 2013 Mar 13. doi:10.1016/j.cjca.2013.01.001.
Metadaten
Titel
Atrial electromechanical delay in type 2 diabetes mellitus
verfasst von
MD Ahmet Akyel
MD Fatih Öksüz
MD Muhammed Karadeniz
MD Mikail Yarlıoğlueş
MD Gökhan Ergün
MD Tayyar Cankurt
MD Ahmet Yozgat
MD Müge Keskin Arıel
MD Yalçın Aral
MD Sani Namık Murat
Publikationsdatum
01.02.2014
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 3-4/2014
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-013-0477-1